Skip to main content
. 2022 Apr 6;13:882452. doi: 10.3389/fimmu.2022.882452

Figure 1.

Figure 1

An overview of cf-tDNA release into biofluids, recovery, detection methods, and current clinical applications benefiting immunotherapies for glioma.